MARTEK BIOSCIENCES (NASDAQ:MATK)
20.39
+0.39 (1.95%)
| MARTEK BIOSCIENCES (NASDAQ:MATK) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $20.00 | 52 Week High | $26.19 | ||
| Open | $20.14 | 52 Week Low | $15.36 | ||
| Day High | $20.49 | P/E | 16.71 | ||
| Day Low | $20.01 | EPS | $1.22 | ||
| Volume | 232,617 | ||||
| More MATK Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| DAR | 3 | FL | 3 |
| GA | 3 | JTX | 3 |
| FIT | 3 | PETM | 3 |
| HOTT | 3 | SIGM | 3 |
| CWTR | 3 | ADBE | 2 |
| C | 2 | F | 2 |
Entities who have mentioned MATK
- Citi | View Related Stories »
- 13G | View Related Stories »
- Canaccord Adams | View Related Stories »
- Banc of America | View Related Stories »
- After-Hours Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- Merrill Lynch | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Barron's | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Vanguard | View Related Stories »
- ADP Employment Report | View Related Stories »
- Crude Oil | View Related Stories »
- Trading Radar | View Related Stories »
- Dividend | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Layoffs | View Related Stories »
- Barack Obama | View Related Stories »
- D.A. Davidson | View Related Stories »
- B. Riley | View Related Stories »
- Options | View Related Stories »
- Needham & Company | View Related Stories »
- Deutsche Bank | View Related Stories »
View All Major News StreetInsider.com Major News for MATK
- Martek Biosciences (MATK) Enters Agreement to Buy Amerifit Brands for $200M in Cash; Raises Q1 Guidance
- Martek Biosciences (MATK) Reports Inline Q4 EPS of $0.33; Guides Q1, FY10
- Martek Biosciences (MATK) Misses Q3 Revenue View; Guides Q4 & FY09
View All ReportsStreetInsider.com Reports on MATK
- Notable Mergers and Acquisitions of the Day 1/21: ORCL/JAVA, MATK, FIT, A/VARI
- Martek Biosciences (MATK) Enters Agreement to Buy Amerifit Brands for $200M in Cash; Raises Q1 Guidance
- Martek Biosciences (MATK) Reports Inline Q4 EPS of $0.33; Guides Q1, FY10
- Martek Bio (MATK) December options prices elevated into EPS and outlook
- Canaccord Adams Reiterates a 'Buy' Rating on NBTY (NTY), Adds to Best Ideas List
View All Press ReleasesCompany Press Releases on MATK
- Charterhouse Group To Sell Amerifit Brands To Martek in $200 Million Transaction
- Martek Announces Agreement to Purchase Amerifit Brands
- Martek to Present at Upcoming Needham Conference
- Martek Announces Fourth Quarter and FY 2009 Financial Results
StreetInsider Reports on MATK by Category
View All BlogsBlogs on MATK
- Same Strategy, Different Players: Static Investing in 2010
- Value Investing: Strategies for Improving Your Returns
- Backtesting a Value Strategy
- Martek Biosciences: Can It Turn Algae into Gold, Or at the Least Oil?
- Good News for Honeywell, Eaton, Nissan, Martek, Enova
View All FilingsSEC Filings on MATK
- Form SC 13G/A MARTEK BIOSCIENCES CORP Filed by: STATE STREET BANK & TRUST CO
- Form SC 13G MARTEK BIOSCIENCES CORP Filed by: VANGUARD GROUP INC
- Form SC 13G MARTEK BIOSCIENCES CORP Filed by: BlackRock Inc.
- Form 8-K MARTEK BIOSCIENCES CORP For: Jan 21
- Form 8-K MARTEK BIOSCIENCES CORP For: Jan 21
Comments on MATK
No comments are currently available.
